| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate |
2014-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c2bb533476fc1cf7012a2171b4658a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0313856e02e2b465fc1e7c4a44b4d6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23b28fa7678d5d070c0c8cc1785c1ec8 |
| publicationDate |
2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015035419-A1 |
| titleOfInvention |
Dosages of gip/glp-1 co-agonist peptides for human administration |
| abstract |
Provided herein are methods of treating obesity or diabetes, as well as related methods of reducing weight gain or inducing weight loss, treating hyperglycemia, or improving glycemic control in humans treated with a dose range of a GIP/GLP-1 coagonist peptide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11779648-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113383014-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021093883-A1 |
| priorityDate |
2013-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |